株式会社Rhelixa（レリクサ）

Strength
About Us
Contact

SERVICE

Next Generation Sequencing
Bioinformatics

Cloud-based Tool RIAS®
for Medical Life Science Research

COMPANY PROFILE

OVERVIEW

Company

Rhelixa, Inc.

Office / Lab

5F KDX Ginza East Bldg., 3-7-2, Chuo-ku, Irifune, Tokyo, Japan.

Foundation

Feb. 2015

business

Omics research and consulting services
Development and operation of cloud-based services

Certification

JIS Q 27001:2014(ISO/IEC 27001:2013)　MSA-IS-612

PARTNER

BUSINESS DATAas of Mar. 2023

Company

188company

Institute

275institute

Project

5348 project

MEMBER

MANAGEMENT

Representative Director, CEO

Tomoyuki Matsuno

After graduating from Yokohama National University, Tomoyuki joined Mitsubishi Corporation, where he was in charge of global sales and trading of derivatives products. Then worked for a U.S. trading company before becoming CEO of Rhelixa.

Director, COO

Takao Uchikai

Takao Uchikai holds a Ph.D. in Life Sciences from Tokyo Metropolitan University. Takao worked as a Next Generation Sequencing Lab Manager at Eurofin Genomics, Inc. and established genetic testing and bacterial flora testing at Anicom.

Director, CTO (Founder)

Ryo Nakaki

Ryo Nakaki holds a Ph.D. in Engineering from Department of Genome Science, Research Center for Advanced Science and Technology, Tokyo University. Ryo specializes in the analysis of large-scale omics data, especially epigenomic analysis. Ryo is a councilor of the Japanese Society of Anti-Aging Medicine.

General Manager, Administration Dept.

Ryota Kamiya

After graduating from Yokohama National University, Ryota joined Nippon Life Insurance Company, where he was engaged in corporate planning and management of group companies in the Asset Management Division. After joining Rhelixa,He reformed the company's internal systems and management infrastructure to take the company public.

ADVISER

Yasuharu Kanki　(M.D., Ph.D.)

Graduated from Kyoto University School of Medicine (M.D.). Obtained a Ph.D. from the Laboratory for Systems Biology and Medicine (LSBM) at the University of Tokyo's Research Center for Advanced Science and Technology. Has experience studying at the National Institutes of Health (NIH). Has numerous research publications on vascular epigenomics.

Yukihiro Maru　(Ph.D.)

Established Leave a Nest Co., Ltd. in 2002. Engaged in the "knowledge production industry," creating new businesses by combining technologies and knowledge from various fields. Building one of the largest deep tech ecosystems in Asia, and working on solving global-scale challenges. Involved in the launch of numerous deep tech ventures, including Euglena Co., Ltd.

Co-authored Papers

A de novo genome assembly of Solanum verrucosum Schlechtendal, a Mexican diploid species geographically isolated from other diploid A-genome species of potato relatives.
G3 (Bethesda). 2022 Jul 1:jkac166. doi: 10.1093/g3journal/jkac166. Online ahead of print.
Spatiotemporal dynamics of SETD5-containing NCoR-HDAC3 complex determines enhancer activation for adipogenesis.
Nat Commun. 2021 Dec 2;12(1):7045. doi: 10.1038/s41467-021-27321-5.
Inhibition of cardiac PERK signaling promotes peripartum cardiac dysfunction.
Sci Rep. 2021 Sep 21;11(1):18687. doi: 10.1038/s41598-021-98344-7.
PERK inhibition attenuates vascular remodeling in pulmonary arterial hypertension caused by BMPR2 mutation.
Sci Signal. 2021 Jan 26;14(667):eabb3616. doi: 10.1126/scisignal.abb3616.
Coordinated demethylation of H3K9 and H3K27 is required for rapid inflammatory responses of endothelial cells.
EMBO J. 2020 Mar e103949. doi.org/10.15252/embj.2019103949
Type I Interferon Delivery by iPSC-Derived Myeloid Cells Elicits Antitumor Immunity via XCR1+ Dendritic Cells.
Cell Rep. 2019 Oct 1;29(1):162-175.e9. doi: 10.1016/j.celrep.2019.08.086.
A de novo genome assembly of Solanum verrucosum Schlechtendal, a Mexican diploid species geographically isolated from other diploid A-genome species of potato relatives.
G3 (Bethesda). 2022 Jul 1:jkac166. doi: 10.1093/g3journal/jkac166. Online ahead of print.
Spatiotemporal dynamics of SETD5-containing NCoR-HDAC3 complex determines enhancer activation for adipogenesis.
Nat Commun. 2021 Dec 2;12(1):7045. doi: 10.1038/s41467-021-27321-5.
Inhibition of cardiac PERK signaling promotes peripartum cardiac dysfunction.
Sci Rep. 2021 Sep 21;11(1):18687. doi: 10.1038/s41598-021-98344-7.
PERK inhibition attenuates vascular remodeling in pulmonary arterial hypertension caused by BMPR2 mutation.
Sci Signal. 2021 Jan 26;14(667):eabb3616. doi: 10.1126/scisignal.abb3616.
Coordinated demethylation of H3K9 and H3K27 is required for rapid inflammatory responses of endothelial cells.
EMBO J. 2020 Mar e103949. doi.org/10.15252/embj.2019103949
Type I Interferon Delivery by iPSC-Derived Myeloid Cells Elicits Antitumor Immunity via XCR1+ Dendritic Cells.
Cell Rep. 2019 Oct 1;29(1):162-175.e9. doi: 10.1016/j.celrep.2019.08.086.